References
- Siegel RL , MillerKD, FedewaSAet al. Colorectal cancer statistics, 2017. CA: Cancer J. Clin. 67 (3), 177 – 193 (2017).
- Renuka , AgnihotriN, SinghAP, BhatnagarA. Involvement of regulatory T cells and their cytokines repertoire in chemopreventive action of fish oil in experimental colon cancer.Nutr. Cancer68 (7), 1181 – 1191 (2016).
- Renuka , KumarS, SharmaB, SharmaP, AgnihotriN. n-3 PUFAs: an elixir in prevention of colorectal cancer.Curr. Colorectal Cancer Rep.11 (3), 141 – 149 (2015).
- Irrazábal T , BelchevaA, GirardinSE, MartinA, PhilpottDJ. The multifaceted role of the intestinal microbiota in colon cancer.Mol. Cell54 (2), 309 – 320 (2014).
- Sun J , KatoI. Gut microbiota, inflammation and colorectal cancer.Genes Dis.3 (2), 130 – 143 (2016).
- Dahiya DK , Renuka, PuniyaMet al. Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: a review. Front. Microbiol. 8 (563), doi: 10.3389/fmicb.2017.00563 ( Epub ahead of print ) ( 2017).
- Roy S , TrinchieriG. Microbiota: a key orchestrator of cancer therapy.Nat. Rev. Cancer17 (5), 271 – 285 (2017).
- Gao R , GaoZ, HuangL, QinH. Gut microbiota and colorectal cancer.European J. Clin. Microbiol. Infect. Dis.1 – 13 (2017).
- Yu T , GuoF, YuYet al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170 (3), 548 – 563.e516 (2017).
- Amitay EL , WernerS, VitalMet al. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study. Carcinogenesis 38 (8), 781 – 788 (2017).
- Lu R , WuS, ZhangYet al. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis 3 (6), e105 (2014).
- Amarnani R , RaposeA. Colon cancer and enterococcus bacteremia co-affection: a dangerous alliance.J. Infect. Public Health10 (5), 681 – 684 (2017).
- Tarantino G , FinelliC. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease.Fut. Microbiol.10 (5), 889 – 902 (2015).
- Dahiya DK , PuniyaAK. Evaluation of survival, free radical scavenging and human enterocyte adherence potential of lactobacilli with anti-obesity and anti-inflammatory cla isomer-producing attributes.J. Food Process. Preserv.39 (6), 2866 – 2877 (2015).
- Rohwer F . Global phage diversity.Cell113 (2), 141 (2003).
- Ogilvie LA , JonesBV. The human gut virome: a multifaceted majority.Front. Microbiol.6 (2015).
- Scarpellini E , IaniroG, AttiliF, BassanelliC, De SantisA, GasbarriniA. The human gut microbiota and virome: potential therapeutic implications.Digest. Liver Dis.47 (12), 1007 – 1012 (2015).
- Reyes A , HaynesM, HansonNet al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466 (7304), 334 – 338 (2010).
- Columpsi P , SacchiP, ZuccaroVet al. Beyond the gut bacterial microbiota: the gut virome. J. Med. Virol. 88 (9), 1467 – 1472 (2016).
- Virgin HW . The virome in mammalian physiology and disease.Cell157 (1), 142 – 150 (2014).
- Norman JM , HandleySA, BaldridgeMTet al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160 (3), 447 – 460 (2015).
- Minot S , SinhaR, ChenJet al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21 (10), 1616 – 1625 (2011).
- Kim MS , BaeJW. Spatial disturbances in altered mucosal and luminal gut viromes of diet-induced obese mice.Environmental Microbiol. doi: 10.1111/1462-2920.13182 ( Epub ahead of print ) ( 2016).
- Reyes A , SemenkovichNP, WhitesonK, RohwerF, GordonJI. Going viral: next-generation sequencing applied to phage populations in the human gut.Nat. Rev. Microbiol.10 (9), 607 – 617 (2012).